Diabetes, Parkinson's disease
Novel drug molecule could help treat Parkinson's disease in young patients
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain cells of young Parkinson's patients,
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
Study links diabetes drugs to lower risk of dementia and Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the .
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
WMNF1d
USF researcher integral part of FDA’s approval of new Parkinson’s drug
The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.
How a Colorado Parkinson’s group uses climbing to help stave off effects of the disease
Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...
Armed robbery in Revesby1d
New Drug Molecule May Offer Young Parkinson's Patients Hope
A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according ...
Medical News Today3d
Type 2 drugs could lower dementia, Parkinson's disease risk
Now, a large cohort study has shown use of these drugs is associated with a lower risk of developing these neurodegenerative conditions. Parkinson’s disease and Alzheimer’s disease risk are ...
Medical Xpress3d
Novel drug molecule could help treat Parkinson's disease in young patients
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain ...